EcoDrugPlus

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSELUG00000016940
Gene Symbol: CXCR1
3 Cross references
275 Possible Orthologues:

C-Reactive Protein

Ensembl ID : ENSELUG00000024979
Gene Symbol: LOC105028464
2 Cross references
346 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSELUG00000012690
Gene Symbol: CFTR
3 Cross references
217 Possible Orthologues:

D(4) Dopamine Receptor

Ensembl ID : ENSELUG00000018550
Gene Symbol: LOC105007372
3 Cross references
176 Possible Orthologues:

D(4) Dopamine Receptor

Ensembl ID : ENSELUG00000006156
Gene Symbol: LOC105028893
4 Cross references
175 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSELUG00000023659
Gene Symbol: DNMT1
3 Cross references
212 Possible Orthologues:

Dna Topoisomerase 1

Ensembl ID : ENSELUG00000004758
Gene Symbol: LOC105017359
3 Cross references
208 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSELUG00000002025
Gene Symbol: TOP1
3 Cross references
201 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSELUG00000011305
Gene Symbol: TOP2A
1 Cross references
207 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSELUG00000009054
Gene Symbol: TOP2B
1 Cross references
209 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSELUG00000016121
Gene Symbol: EML4
4 Cross references
212 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSELUG00000007311
Gene Symbol: EPHA3
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).